ClariVest Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,790
Closed -$1.85M 832
2020
Q4
$1.85M Hold
14,790
0.06% 219
2020
Q3
$1.5M Sell
14,790
-510
-3% -$52K 0.05% 257
2020
Q2
$1.49M Buy
15,300
+1,200
+9% +$112K 0.04% 270
2020
Q1
$1.17M Buy
14,100
+700
+5% +$68.3K 0.04% 273
2019
Q4
$1.49M Sell
13,400
-300
-2% -$30.9K 0.03% 288
2019
Q3
$1.36M Sell
13,700
-61,799
-82% -$6.14M 0.03% 309
2019
Q2
$7.49M Sell
75,499
-9,128
-11% -$871K 0.17% 128
2019
Q1
$9.33M Sell
84,627
-11,275
-12% -$1.18M 0.19% 122
2018
Q4
$8.82M Buy
95,902
+27,612
+40% +$2.79M 0.19% 108
2018
Q3
$7.53M Sell
68,290
-1,244
-2% -$130K 0.13% 120
2018
Q2
$6.49M Sell
69,534
-40,552
-37% -$3.49M 0.11% 149
2018
Q1
$9.13M Sell
110,086
-979
-0.9% -$87K 0.16% 116
2017
Q4
$10.1M Buy
111,065
+22,980
+26% +$1.91M 0.17% 103
2017
Q3
$6.71M Hold
88,085
0.16% 138
2017
Q2
$6.61M Sell
88,085
-50
-0.1% -$3.47K 0.16% 125
2017
Q1
$5.75M Buy
+88,135
New +$5.19M 0.14% 141

Other funds holding PRAH

ClariVest Asset Management's PRAH Position: Q1 2021 in Review

ClariVest Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 14,790 shares — an estimated $1.85M sold.

ClariVest Asset Management first reported a position in PRAH in Q1 2017 and held it in 16 quarters. The position peaked at $10.1M in Q4 2017. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • ClariVest Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 14,790 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $1.85M.
  • ClariVest Asset Management first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 16 quarters.
  • ClariVest Asset Management's PRA Health Sciences, Inc. position peaked at $10.1M in Q4 2017.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on ClariVest Asset Management's 13F filing for Q1 2021, filed 13 May 2021.